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Background:  Although exercise training (ET) is recommended in patients with heart failure (HF), the improvement in exercise capacity is variable 
and the predictors of good/poor responders have not been fully studied. 
Methods:  To determine the predictors of poor responders to exercise training, we studied 191 patients who participated in ET in our cardiac 
rehabilitation (CR) program. The patients were divided into two groups according to the changes in peak oxygen uptake (PVO2) measured by 
cardiopulmonary exercise testing at the beginning and the end of 3-month CR program; 143 patients with an increase in PVO2 (Responders) and 48 
patients with a decrease in PVO2 (Nonresponders). 
Results:  There were no differences in ejection fraction or BNP between the two groups. Among Nonresponders, the prevalences of elderly patients 
(>=75 years, p=0.011) and women (p<0.001) were higher than in Responders. In addition, percentage of predicted PVO2 (%predict PVO2) was 
higher in Nonresponders than in Responders (p=0.007). Moreover, non-ischemic cardiomyopathy other than idiopathic dilated or hypertensive 
cardiomyopathy (such as hypertrophic cardiomyopathy or cardiac sarcoidosis) exhibited poor responses. 
Conclusions:  Elderly patients, women, patients with preserved exercise capacity, and some cardiomyopathies are the predictors of poor 
responders in ET for HF patients. These patients may require individualized ET prescriptions.
